• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于羧肽酶A、B和N对缓激肽、赖氨酰缓激肽及激肽降解产物的消化作用的研究。

Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N.

作者信息

Sheikh I A, Kaplan A P

出版信息

Biochem Pharmacol. 1986 Jun 15;35(12):1957-63. doi: 10.1016/0006-2952(86)90727-6.

DOI:10.1016/0006-2952(86)90727-6
PMID:3718539
Abstract

We have compared the digestion of bradykinin, lysyl bradykinin, and kinin degradation products by carboxypeptidases N, B and A (CPN, CPB and CPA). Carboxypeptidase N removed the C-terminal arginine from bradykinin or lysyl bradykinin to leave the des-Arg derivative of each, and no further degradation occurred regardless of enzyme concentration or time of incubation. However, both CPB and CPA degraded the des-Arg derivatives to remove the C-terminal phenylalanine. The inhibitory effect of phosphate ions upon this activity of CPB (but not CPA) suggests that CPA may be responsible for the formation of free phenylalanine seen upon degradation of kinins in plasma or serum. However, angiotensin converting enzyme degraded des-Arg9-bradykinin in plasma or serum prior to such Phe removal to yield the pentapeptide Arg-Pro-Pro-Gly-Phe and the tripeptide Ser-Pro-Phe. We demonstrated that CPB degraded Arg-Pro-Pro-Gly-Phe but not Ser-Pro-Phe; this reaction was also inhibited by phosphate ions. Carboxypeptidase A, on the other hand, liberated Phe from both peptides in phosphate-buffered saline and accounted, at least in part, for the free phenylalanine detected. Carboxypeptidase N did not digest the aforementioned pentapeptide or tripeptide. It is clear that carboxypeptidase B and carboxypeptidase A had overlapping activities, depending upon the substrate tested, and were distinguished by the effects of different ionic environments. We further suggest a role for carboxypeptidases other than CPN in the degradation of kinins in human plasma or serum.

摘要

我们比较了羧肽酶N、B和A(CPN、CPB和CPA)对缓激肽、赖氨酰缓激肽及激肽降解产物的消化作用。羧肽酶N从缓激肽或赖氨酰缓激肽上去除C末端的精氨酸,留下各自的去-Arg衍生物,无论酶浓度或孵育时间如何,均未发生进一步降解。然而,CPB和CPA都能降解去-Arg衍生物以去除C末端的苯丙氨酸。磷酸根离子对CPB(而非CPA)的这种活性具有抑制作用,这表明CPA可能是血浆或血清中激肽降解时产生游离苯丙氨酸的原因。然而,在去除苯丙氨酸之前,血管紧张素转换酶可降解血浆或血清中的去-Arg9-缓激肽,生成五肽Arg-Pro-Pro-Gly-Phe和三肽Ser-Pro-Phe。我们证明CPB可降解Arg-Pro-Pro-Gly-Phe,但不能降解Ser-Pro-Phe;该反应也受到磷酸根离子的抑制。另一方面,羧肽酶A在磷酸盐缓冲盐水中可从这两种肽中释放出苯丙氨酸,这至少部分解释了所检测到的游离苯丙氨酸的来源。羧肽酶N不能消化上述五肽或三肽。很明显,羧肽酶B和羧肽酶A的活性存在重叠,这取决于所测试的底物,并且可通过不同离子环境的影响加以区分。我们进一步认为,除CPN外,其他羧肽酶在人血浆或血清中激肽的降解过程中也发挥作用。

相似文献

1
Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N.关于羧肽酶A、B和N对缓激肽、赖氨酰缓激肽及激肽降解产物的消化作用的研究。
Biochem Pharmacol. 1986 Jun 15;35(12):1957-63. doi: 10.1016/0006-2952(86)90727-6.
2
Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products.
Biochem Pharmacol. 1989 Mar 15;38(6):993-1000. doi: 10.1016/0006-2952(89)90290-6.
3
Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme.血管紧张素转换酶对缓激肽、赖氨酰缓激肽和去-精氨酸9-缓激肽的消化研究。
Biochem Pharmacol. 1986 Jun 15;35(12):1951-6. doi: 10.1016/0006-2952(86)90726-4.
4
Development of a radioimmunoassay for [DES-ARG9]-bradykinin.[去精氨酸9]-缓激肽放射免疫测定法的开发。
Biochem Pharmacol. 1983 Jan 15;32(2):337-42. doi: 10.1016/0006-2952(83)90564-6.
5
Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.肿瘤腹水中激肽的降解途径及激肽酶抑制剂的抑制作用:高效液相色谱分析
Agents Actions. 1990 Mar;29(3-4):172-80. doi: 10.1007/BF01966443.
6
T-kinin is resistant to hydrolysis by angiotensin I-converting enzyme.T-激肽对血管紧张素I转换酶的水解作用具有抗性。
Immunopharmacology. 1996 May;32(1-3):166-8. doi: 10.1016/0162-3109(95)00083-6.
7
Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists.
Am J Physiol Heart Circ Physiol. 2003 Jun;284(6):H1959-68. doi: 10.1152/ajpheart.00036.2003. Epub 2003 Mar 6.
8
Degradation of plasma kinins by an enzyme from Pseudomonas aeruginosa.铜绿假单胞菌一种酶对血浆激肽的降解作用。
Br J Pharmacol Chemother. 1967 Nov;31(3):401-6. doi: 10.1111/j.1476-5381.1967.tb00407.x.
9
Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.跨膜区V和VI在结合去精氨酸激肽C末端序列中的重要作用。
Int Immunopharmacol. 2008 Feb;8(2):282-8. doi: 10.1016/j.intimp.2007.09.007. Epub 2007 Oct 4.
10
Kininases and vascular responses to kinins.
Eur J Pharmacol. 1982 Feb 26;78(2):167-74. doi: 10.1016/0014-2999(82)90233-3.

引用本文的文献

1
COVID-19 and Lung Mast Cells: The Kallikrein-Kinin Activation Pathway.COVID-19 与肺肥大细胞:激肽释放酶-激肽激活途径。
Int J Mol Sci. 2022 Feb 2;23(3):1714. doi: 10.3390/ijms23031714.
2
gC1qR Antibody Can Modulate Endothelial Cell Permeability in Angioedema.gC1qR抗体可调节血管性水肿中内皮细胞的通透性。
Inflammation. 2022 Feb;45(1):116-128. doi: 10.1007/s10753-021-01532-w. Epub 2021 Sep 7.
3
Pathophysiology and underlying mechanisms in hereditary angioedema.遗传性血管性水肿的病理生理学及潜在机制
Balkan Med J. 2021 Mar;38(2):82-88. doi: 10.4274/balkanmedj.galenos.2020.2020.10.166.
4
Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.激肽释放酶-激肽系统在神经紊乱中的意义:探寻潜在的生物标志物和机制。
Prog Neurobiol. 2018 Jun-Aug;165-167:26-50. doi: 10.1016/j.pneurobio.2018.01.003. Epub 2018 Jan 31.
5
Angioedema.血管性水肿。
World Allergy Organ J. 2008 Jun;1(6):103-13. doi: 10.1097/WOX.0b013e31817aecbe.
6
Cross-talk between the complement and the kinin system in vascular permeability.补体系统与激肽系统在血管通透性中的相互作用。
Immunol Lett. 2011 Oct 30;140(1-2):7-13. doi: 10.1016/j.imlet.2011.06.006. Epub 2011 Jul 6.
7
The contribution of gC1qR/p33 in infection and inflammation.gC1qR/p33在感染与炎症中的作用
Immunobiology. 2007;212(4-5):333-42. doi: 10.1016/j.imbio.2006.11.011. Epub 2007 Jan 3.
8
Bradykinin formation. Plasma and tissue pathways and cellular interactions.缓激肽的形成。血浆和组织途径以及细胞相互作用。
Clin Rev Allergy Immunol. 1998 Winter;16(4):403-29. doi: 10.1007/BF02737659.
9
Localization and regulation of the renal kallikrein kinin system: possible relations to renal transport functions.肾激肽释放酶-激肽系统的定位与调节:与肾转运功能的可能关系
Klin Wochenschr. 1988 Sep 15;66(18):849-56. doi: 10.1007/BF01728946.
10
Metabolism of bradykinin and angiotensin I by human basilar artery and rabbit aorta.
Naunyn Schmiedebergs Arch Pharmacol. 1987 May;335(5):551-4. doi: 10.1007/BF00169123.